| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Lorenz Kevin | Director | C/O FORTRESS BIOTECH, INC., 1111 KANE CONCOURSE SUITE 301, BAY HARBOR ISLANDS | /s/ Samuel Berry, Attorney-in-Fact | 05 Jan 2026 | 0001772558 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FBIO | common stock, par value $0.001 | Award | $0 | +27,322 | +37% | $0.000000 | 101,009 | 01 Jan 2026 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The Reporting Person was granted 27,322 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2027, 2028, and 2029, subject to continued service. |